Target intelligence / Profile preview

Lymphatic system macrophages

Molecular classification
Other
01

Overview

Lymphatic system macrophages are a heterogeneous population of myeloid cells located within the lymph nodes, including subcapsular sinus (SSM), medullary sinus (MSM), and medullary cord macrophages (MCM). These cells function as a vital biological filter, capturing lymph-borne antigens, viruses, and bacteria to prevent systemic dissemination (Martinez-Pomares & Gordon, 2012, Trends in Immunology). They play a crucial role in the initiation of adaptive immunity by presenting captured antigens to B and T lymphocytes. In oncology, SSMs can limit tumor progression by sequestering tumor-derived extracellular vesicles, but they may also be subverted to promote a pro-metastatic environment (Bernhard et al., 2021, Nature Communications). Although they are a cellular population rather than a single protein, they are targeted by diagnostic agents like Technetium Tc 99m tilmanocept, which binds the mannose receptor (CD206) to map sentinel lymph nodes (Wallace et al., 2003, Journal of Nuclear Medicine). Therapeutic strategies explore modulating these macrophages to improve vaccine responses or to deliver anti-inflammatory payloads in autoimmune diseases (Gordon & Plüddemann, 2017, BMC Biology). Their strategic location makes them ideal targets for nanoparticle-based drug delivery systems aimed at the lymphatic system.

Other names
Lymph node macrophagesSubcapsular sinus macrophagesMedullary sinus macrophagesMedullary cord macrophagesSinusoidal macrophages
02

Mechanism of action

Receptor-mediated binding and uptake by macrophage-specific surface proteins, such as the mannose receptor (CD206), for diagnostic imaging or therapeutic delivery (Wallace et al., 2003, Journal of Nuclear Medicine).

03

Biological functions

Immune responsePhagocytosisAntigen presentationLymph filtrationTissue remodelingCytokine production
04

Disease associations

CancerInfectionInflammationAutoimmunityLymphedema
05

Safety considerations

Impaired immune surveillanceIncreased susceptibility to lymphogenous spread of infectionsPotential for systemic inflammatory responsesOff-target effects on other tissue-resident macrophage populations
06

Interacting drugs

Technetium Tc 99m tilmanocept

2 more in the full profile.

07

Biomarkers

CD169 (Siglec-1)CD206 (Mannose receptor)MARCOCD163CD68LYVE-1

Beyond the preview

Go deeper on Lymphatic system macrophages.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic system macrophages.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call